Results 1 to 10 of about 67,878 (296)

Immunomodulation by thalidomide and thalidomide analogues [PDF]

open access: bronzeAnnals of the Rheumatic Diseases, 1999
Tumour necrosis factor α (TNFα), a key cytokine involved in the host immune response, also contributes to the pathogenesis of both infectious and autoimmune diseases. To ameliorate the pathology resulting from TNFα in these clinical settings, strategies for the inhibition of this cytokine have been developed.
L G, Corral, G, Kaplan
openaire   +4 more sources

Thalidomide‐induced teratogenesis: History and mechanisms [PDF]

open access: yesBirth Defects Research Part C: Embryo Today Reviews, 2015
Peer reviewedPublisher ...
Neil A Vargesson
exaly   +3 more sources

Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial

open access: yesSignal Transduction and Targeted Therapy, 2021
Thalidomide induces γ-globin expression in erythroid progenitor cells, but its efficacy on patients with transfusion-dependent β-thalassemia (TDT) remains unclear.
Weida Wang, Guang-Biao Zhou
exaly   +2 more sources

Myelodysplastic Syndrome With Complex Chromosomal Karyotype Abnormalities Complicated by Multiple Intestinal Perforations: A Case Report and Literature Review. [PDF]

open access: yesCase Rep Gastrointest Med
Background Myelodysplastic syndromes (MDSs) are clonal hematopoietic disorders often associated with cytogenetic abnormalities, among which trisomy 8 is one of the most common abnormalities. Trisomy 8 is linked to autoimmune manifestations, including Behçet‐like disease, especially with gastrointestinal involvement.
Niu ZY   +5 more
europepmc   +2 more sources

Thalidomide [PDF]

open access: yesThe Lancet, 2004
Despite its history as a human teratogen, thalidomide is emerging as a treatment for cancer and inflammatory diseases. Although the evolution of its clinical application could not have been predicted from the tragedy associated with its misuse in the past, its history serves as a lesson in drug development that underscores the need to understand the ...
Michael E, Franks   +2 more
  +7 more sources

Long term thalidomide therapy’s efficacy and safety in transfusion-dependent beta thalassemia major patients: a systematic review

open access: diamondKhyber Medical University Journal
OBJECTIVE: To identify the effectiveness and safety of thalidomide in transfusion-dependent beta Thalassemia Major (TDBTM) patients. METHODS: A comprehensive search of PubMed, Cochrane Library, and Embase was conducted between January 01, 2014, and ...
Tahira Atta   +4 more
doaj   +3 more sources

EBV+ and Kaposi's Sarcoma Herpesvirus-Associated Multicentric Castleman Disease in a Patient With HIV Infection: A Case Report. [PDF]

open access: yesCase Rep Infect Dis
Multicentric Castleman disease is a rare proliferative disease of lymphoid tissue. It has rarely been reported in Asian countries, particularly in HIV‐positive patients. Here, we report a case of Kaposi’s sarcoma herpesvirus‐associated Multicentric Castleman disease (KSHV‐MCD).
Huang MY   +5 more
europepmc   +2 more sources

Thalidomide affects limb formation and multiple myeloma related genes in human induced pluripotent stem cells and their mesoderm differentiation

open access: yesBiochemistry and Biophysics Reports, 2021
Although thalidomide is highly teratogenic, it has been prescribed for treating multiple myeloma and Hansen's disease. However, its mechanism of action is not fully understood.
Maho Shimizu   +6 more
doaj   +1 more source

Thalidomide Suppresses Angiogenesis Through the Signal Transducer and Activator of Transcription 3/SP4 Signaling Pathway in the Peritoneal Membrane

open access: yesFrontiers in Physiology, 2021
Peritoneal angiogenesis is the key pathophysiological factor that limits peritoneal ultrafiltration during peritoneal dialysis (PD) in uremic patients.
Nan Zhu   +8 more
doaj   +1 more source

Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs

open access: yesMolecules, 2020
Due to its antiangiogenic and anti-immunomodulatory activity, thalidomide continues to be of clinical interest despite its teratogenic actions, and efforts to synthesize safer, clinically active thalidomide analogs are continually underway. In this study,
Megan L. Peach   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy